Formulation and method for the prevention and treatment of bone metastases or other bone diseases

Details for Australian Patent Application No. 2009224681 (hide)

Owner Erytech Pharma

Inventors Bourgeaux, Vanessa; Godfrin, Yann

Agent Davies Collison Cave

Pub. Number AU-B-2009224681

PCT Pub. Number WO2009/112493

Priority 0851521 10.03.08 FR

Filing date 10 March 2009

Wipo publication date 17 September 2009

Acceptance publication date 12 January 2012

International Classifications

A61K 31/663 (2006.01)

A61K 35/18 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Erythrocytes

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/112493 Priority application(s): WO2009/112493

12 January 2012 Application Accepted

  Published as AU-B-2009224681

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009224684-Method for generating primate cardiovascular progenitor cells for clinical use from primate embryonic stem cells or embryonic-like state cells, and their applications

2009224675-Herbicidal compositions comprising pyroxasulfone